Susquehanna International Group
NVO

Susquehanna International Group’s Novo Nordisk NVO Stock Holding History

Susquehanna International Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$563M Buy
15,319,300
+7,908,300
+107% +$375M 0.06% 240
2025
Q4 		$377M Buy
7,411,000
+524,200
+8% +$26.8M 0.04% 329
2025
Q3 		$382M Buy
6,886,800
+1,096,500
+19% +$64.2M 0.04% 334
2025
Q2 		$400M Buy
5,790,300
+3,433,900
+146% +$234M 0.06% 260
2025
Q1 		$164M Buy
2,356,400
+706,300
+43% +$58.3M 0.03% 455
2024
Q4 		$142M Sell
1,650,100
-729,000
-31% -$78.8M 0.02% 558
2024
Q3 		$283M Buy
2,379,100
+937,500
+65% +$125M 0.05% 301
2024
Q2 		$206M Sell
1,441,600
-451,100
-24% -$59.8M 0.04% 348
2024
Q1 		$243M Buy
1,892,700
+1,043,100
+123% +$124M 0.04% 357
2023
Q4 		$87.9M Sell
849,600
-411,300
-33% -$40.7M 0.02% 733
2023
Q3 		$115M Buy
1,260,900
+464,900
+58% +$41M 0.02% 562
2023
Q2 		$64.4M Buy
796,000
+126,800
+19% +$10.4M 0.01% 837
2023
Q1 		$53.2M Buy
669,200
+222,000
+50% +$15.7M 0.01% 913
2022
Q4 		$30.3M Buy
447,200
+169,400
+61% +$9.93M 0.01% 1190
2022
Q3 		$13.8M Buy
277,800
+95,600
+52% +$5.12M ﹤0.01% 1781
2022
Q2 		$10.2M Sell
182,200
-132,800
-42% -$7.37M ﹤0.01% 2183
2022
Q1 		$17.5M Buy
315,000
+103,400
+49% +$5.31M ﹤0.01% 1865
2021
Q4 		$11.8M Buy
211,600
+66,000
+45% +$3.58M ﹤0.01% 2487
2021
Q3 		$6.99M Sell
145,600
-161,800
-53% -$7.82M ﹤0.01% 3403
2021
Q2 		$12.9M Buy
307,400
+36,400
+13% +$1.41M ﹤0.01% 2577
2021
Q1 		$9.13M Sell
271,000
-194,200
-42% -$6.92M ﹤0.01% 2918
2020
Q4 		$16.2M Buy
465,200
+310,200
+200% +$10.7M ﹤0.01% 1965
2020
Q3 		$5.38M Sell
155,000
-73,200
-32% -$2.44M ﹤0.01% 2958
2020
Q2 		$7.47M Sell
228,200
-19,800
-8% -$632K ﹤0.01% 2481
2020
Q1 		$7.46M Sell
248,000
-40,200
-14% -$1.2M ﹤0.01% 2090
2019
Q4 		$8.34M Sell
288,200
-292,200
-50% -$8.09M ﹤0.01% 2295
2019
Q3 		$15M Buy
580,400
+358,800
+162% +$9.07M 0.01% 1572
2019
Q2 		$5.66M Buy
221,600
+37,200
+20% +$919K ﹤0.01% 2555
2019
Q1 		$4.82M Sell
184,400
-23,600
-11% -$580K ﹤0.01% 2499
2018
Q4 		$4.79M Sell
208,000
-41,400
-17% -$920K ﹤0.01% 2331
2018
Q3 		$5.88M Sell
249,400
-5,400
-2% -$132K ﹤0.01% 2492
2018
Q2 		$5.88M Buy
254,800
+84,200
+49% +$2M ﹤0.01% 2519
2018
Q1 		$4.2M Buy
170,600
+81,200
+91% +$2.13M ﹤0.01% 2759
2017
Q4 		$2.4M Sell
89,400
-66,000
-42% -$1.68M ﹤0.01% 3593
2017
Q3 		$3.74M Sell
155,400
-235,800
-60% -$5.33M ﹤0.01% 2909
2017
Q2 		$8.39M Sell
391,200
-139,400
-26% -$2.81M ﹤0.01% 1854
2017
Q1 		$9.09M Buy
530,600
+238,000
+81% +$4.14M ﹤0.01% 1712
2016
Q4 		$5.25M Sell
292,600
-226,600
-44% -$4.11M ﹤0.01% 2353
2016
Q3 		$10.8M Buy
519,200
+280,600
+118% +$6.96M 0.01% 1473
2016
Q2 		$6.42M Sell
238,600
-367,600
-61% -$10.1M ﹤0.01% 1899
2016
Q1 		$16.4M Buy
606,200
+507,800
+516% +$13.6M 0.01% 1133
2015
Q4 		$2.86M Buy
98,400
+21,000
+27% +$581K ﹤0.01% 3372
2015
Q3 		$2.1M Sell
77,400
-39,200
-34% -$1.11M ﹤0.01% 4181
2015
Q2 		$3.19M Buy
116,600
+36,600
+46% +$1.03M ﹤0.01% 3730
2015
Q1 		$2.14M Sell
80,000
-94,600
-54% -$2.18M ﹤0.01% 4204
2014
Q4 		$3.69M Buy
174,600
+51,200
+41% +$1.14M ﹤0.01% 3357
2014
Q3 		$2.94M Sell
123,400
-135,600
-52% -$3.12M ﹤0.01% 3938
2014
Q2 		$5.98M Sell
259,000
-154,800
-37% -$3.42M ﹤0.01% 2794
2014
Q1 		$9.45M Sell
413,800
-895,200
-68% -$19.1M ﹤0.01% 2072
2013
Q4 		$24.2M Sell
1,309,000
-724,000
-36% -$12.6M 0.01% 1169
2013
Q3 		$34.4M Buy
2,033,000
+107,000
+6% +$1.8M 0.02% 814
2013
Q2 		$29.8M Buy
+1,926,000
New +$32.1M 0.02% 831

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Susquehanna International Group's NVO Position: Q1 2026 in Review

Susquehanna International Group increased its Novo Nordisk (NVO) stake by 809% in Q1 2026, buying an estimated $468M and bringing the position to 11,106,111 shares worth $408M. The position accounts for 0.05% of the portfolio, ranked #315.

Susquehanna International Group first reported a position in NVO in Q2 2013 and has held it in 48 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Susquehanna International Group held 11,106,111 shares of Novo Nordisk worth $408M as of Q1 2026.
  • Susquehanna International Group bought 9,884,077 Novo Nordisk shares in Q1 2026, an estimated $468M.
  • Novo Nordisk made up 0.05% of Susquehanna International Group's portfolio in Q1 2026, its #315 holding.
  • Susquehanna International Group first reported a position in Novo Nordisk in Q2 2013 and has held it in 48 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.